Found: 26
Select item for more details and to access through your institution.
In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1059, doi. 10.1007/s00280-009-0962-4
- By:
- Publication type:
- Article
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1071, doi. 10.1007/s00280-009-0963-3
- By:
- Publication type:
- Article
Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1079, doi. 10.1007/s00280-009-0964-2
- By:
- Publication type:
- Article
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1085, doi. 10.1007/s00280-009-0965-1
- By:
- Publication type:
- Article
Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1097, doi. 10.1007/s00280-009-0966-0
- By:
- Publication type:
- Article
Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1105, doi. 10.1007/s00280-009-0967-z
- By:
- Publication type:
- Article
Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1115, doi. 10.1007/s00280-009-0969-x
- By:
- Publication type:
- Article
Erlotinib in advanced non-small-cell lung cancer after gefitinib failure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1123, doi. 10.1007/s00280-009-0973-1
- By:
- Publication type:
- Article
Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1129, doi. 10.1007/s00280-009-0974-0
- By:
- Publication type:
- Article
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1139, doi. 10.1007/s00280-009-0975-z
- By:
- Publication type:
- Article
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1149, doi. 10.1007/s00280-009-0977-x
- By:
- Publication type:
- Article
Antineoplastic activity of idazoxan hydrochloride.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Antineoplastic activity of idazoxan hydrochloride.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1157, doi. 10.1007/s00280-009-0978-9
- By:
- Publication type:
- Article
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1165, doi. 10.1007/s00280-009-0979-8
- By:
- Publication type:
- Article
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1173, doi. 10.1007/s00280-009-0980-2
- By:
- Publication type:
- Article
A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1181, doi. 10.1007/s00280-009-0981-1
- By:
- Publication type:
- Article
Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Expression of Na,K-ATPase-β<sub>1</sub> subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1187, doi. 10.1007/s00280-009-0985-x
- By:
- Publication type:
- Article
Thymidylate synthetase allelic imbalance in clear cell renal carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1195, doi. 10.1007/s00280-009-0986-9
- By:
- Publication type:
- Article
Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1201, doi. 10.1007/s00280-009-0987-8
- By:
- Publication type:
- Article
Experimental study of combination therapy with S-1 against pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1211, doi. 10.1007/s00280-009-0990-0
- By:
- Publication type:
- Article
Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1221, doi. 10.1007/s00280-009-0992-y
- By:
- Publication type:
- Article
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1235, doi. 10.1007/s00280-009-0994-9
- By:
- Publication type:
- Article
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1253, doi. 10.1007/s00280-009-0995-8
- By:
- Publication type:
- Article
Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1261, doi. 10.1007/s00280-009-0996-7
- By:
- Publication type:
- Article